Treatment with gonadotropin-releasing hormone agonist (GnRH-a) for at least three months before IVF is detrimental for women with endometriosis.
Key Points
Lay Summary
The long-acting GnRH agonist long protocol as stimulation protocol during IVF treatment in endometriosis patients increases clinical pregnancy and live birth rates.
Key Points
Lay Summary
No overall statistically significant association between alcohol consumption and endometriosis risk was observed.
Key Points
Lay Summary
"Hypoxia-induced unfolded protein response" in endometriosis might be a potential therapeutic target
Key Points
Lay Summary